Publications Office of the EU
Czechia-Prague: Antivirals for systemic use - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Czechia-Prague: Antivirals for systemic use

Overview
  • Published
    16/11/2022
  • Deadline
    14/12/2022
  • Canceled
    23/12/2022
  • Today
    18/09/2026
Status
Canceled
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice v Motole
Place of performance
NUTS code: CZ010 Hlavní město Praha
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
33651400 Antivirals for systemic use
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
The procedure is closed
Procedure details
Tender reference number
174/22
Description

Předmětem plnění této veřejné zakázky jsou průběžné dodávky léčivého přípravku s účinnou látkou Nirmatrelvir a ritonavir, a to dle Přílohy č. 1 Kupní smlouvy - Seznam zboží.

Submission Method
Electronic via:
https://www.egordion.cz/nabidkaGORDION/profilFnm
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
14/12/2022 10:05
Place of performance
CZ010 Hlavní město Praha
CPV code

33651400 - Antivirals for systemic use

Award method
Lowest price
Estimated value
Not available
Final contracted value
The procedure is closed
Award of contract
The procedure is closed
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.